Tumor susceptibility gene 101

From Proteopedia

Jump to: navigation, search

Human tumor susceptibility gene 101 protein (grey) complex with GAG polyprotein peptide (green) (PDB code 1mp4)

Drag the structure with the mouse to rotate

3D structures of tumor susceptibility gene 101

Updated on 06-February-2024

Additional Resources

For additional information, see: Human Immunodeficiency Virus


  • Freed E. 2003. The HIV-Tsg101 Interface: recent advances in a budding field. Trends in Microbiology 11:56-59.
  • Liu F, Stephen Ag, Adamson C, Gousset K, Aman MJ, Freed EO, Fisher RJ, Burke TR, Jr. 2005. Hydrazone and Hydrazide-Containing N-Substituted Glycines as Peptoid Surrogates for Expedited Library Synthesis: Application to the Preparation of Tsg101-Directed HIV-1 Budding Antagonist. Org Lett 8:5163-5168.
  • Macias M, Wiesnera S, Sudolb M. 2002. WW and SH3 domains, two different scaffolds to recognize proline-rich ligands. Protein Domains 513:30-37.
  • Pornillos O, Alam S, Davis D, Sundquist W. 2002. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nature Structural Biology 9:812–817.
  • Pornillos O, Higginson D, Stray K, Fisher R, Garrus J, Payne M, He G, Wang H, Morham S, Sundquist W. 2003. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. The Journal of Cell Biology 162:425-434.
  • Sudol M, Recinos C, Abraczinskas J, Humbert J, Farooq A. 2005. WW or WoW: The domains in a Union of Bliss. Life 57:773-778.
  • Tavassoli A, Lu Q, Gam J, Pan H, Benkovic S, Cohen S. 2008. Inhibition of HIV Budding by a Genetically Selected Cyclic Peptide Targeting the Gag-TSG101 Interaction. American Chemical Society,Chemical Biology 3:757-764.
  • VerPlank L, Bouamr F, LaGrassa T, Agresta B, Kikonyogo A, Leis J, Carter C. 2001. Tsg101, a homolgue of ubiquitin-conjugating (E2) enzymes, binds the L domain of HIV type 1 Pr55Gag. Proceeding of the National Academy of Science 98:7724-7729.
Personal tools